International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.

A Randomised Study to Evaluate and Compare the Safety of Intravenous vs Intramuscular Ketamine in Major Depressive Disorder with Suicidal Ideations

Author(s) Akanksha, Ved Prakash Gupta, Mohd. Asif Seraj, Deoshree Akhouri
Country India
Abstract Background- Depression is a common psychiatric illness that can be very disabling. In severe instances, it can result in suicide. Being an emergency, ketamine has showed rapid response in terminating suicidality and reducing depressive symptoms.
Objectives- The aim of the study was to evaluate and compare the safety of intravenous and intramuscular ketamine in major depressive disorder.
Method- The present study was conducted in the MDD patients with suicidal ideations who were recruited from psychiatry OPD/IPD during the period November 2021 to October 2022. Ketamine was given at a dose of 0.5mg/kg as a single intravenous infusion in 100 ml NS for a period of 40 minutes or a single intramuscular injection on gluteal muscle and safety of ketamine was assessed on semi-structured proforma.
Results- In both groups, most common side effect was anxiety. Other side effects noted were nausea/vomiting, sedation/drowsiness, dizziness, heaviness of head, lightness of body, emotional abreaction, derealisation/depersonalisation, blurred vision, tachycardia, raised blood pressure and elevated mood. All side effects were transient and improved on its own within 24 hours. None of the participants withdrew because of the adverse effects of ketamine. So, ketamine can be a safer alternative when given by im route.
Keywords Depression, suicide, ketamine, intravenous ketamine, intramuscular ketamine
Published In Volume 6, Issue 5, September-October 2024
Published On 2024-09-07
Cite This A Randomised Study to Evaluate and Compare the Safety of Intravenous vs Intramuscular Ketamine in Major Depressive Disorder with Suicidal Ideations - Akanksha, Ved Prakash Gupta, Mohd. Asif Seraj, Deoshree Akhouri - IJFMR Volume 6, Issue 5, September-October 2024. DOI 10.36948/ijfmr.2024.v06i05.26732
DOI https://doi.org/10.36948/ijfmr.2024.v06i05.26732
Short DOI https://doi.org/gwfgzh

Share this